Criticism mounting on Express Scripts merger
Congressional opposition continues to grow to the proposed $29.1 billion merger between pharmacy benefit managers Express Scripts Inc. and Medco Health Solutions, which is being reviewed by the FTC....To view the full article, register now.
Already a subscriber? Click here to view full article